Atlas Trials

Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor

Clinical trial NCT01845675 · COMPLETED

Trial details

NCT number
NCT01845675
Sponsor
Peking Union Medical College Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Well-differentiated Pancreatic Neuroendocrine Tumor
Start date
2013-04-01
Primary completion
2016-11-30
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.